THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.

The Journal of clinical investigation ·Vol. 18 ·No. 5 ·1939-09-00 ·Pages 507-19

Harris JS, Michel HO

Abstract

暂无摘要

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Harris J S

Department of Pediatrics, Duke University School of Medicine, Durham.

Michel H O

References (5)

5 references, click to expand

TOXIC MANIFESTATIONS OF SULFANILAMIDE.
Ann Surg. 1938 Nov;108(5):808-12 PMID: 17857272
A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL.
J Clin Invest. 1938 Nov;17(6):699-710 PMID: 16694616
CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT.
J Clin Invest. 1938 Jul;17(4):445-7 PMID: 16694591
On sulphhaemoglobin.
J Physiol. 1907 Aug 27;36(1):62-7 PMID: 16992884
Methaemoglobinaemia due to Sulphanilamide Therapy.
Can Med Assoc J. 1937 Jul;37(1):62-4 PMID: 20320677

Article Info

Journal

The Journal of clinical investigation

Abbr.

J Clin Invest

ISSN

0021-9738

DOI

Published

1939-09-00

Pages

507-19

Language

English

Region

United States

NLM ID

7802877

PMCID

PMC434896

External Links

Analysis Services